← FDA Drug Approvals (Drugs@FDA)
DIFLUPREDNATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DR REDDYS · Approved 2022-11-16
Drug application
- FDA Application #
ANDA214894- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DIFLUPREDNATE
- Generic name
- DIFLUPREDNATE OPHTHALMIC
- Active ingredients
- DIFLUPREDNATE
- Dosage form
- EMULSION
- Route
- OPHTHALMIC
- Marketing status
- Prescription
- Sponsor
- DR REDDYS
- Manufacturer
- Dr. Reddy's Laboratories Inc.
- First approval
- 2022-11-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown